D'Agata V, Cavallaro S
Istituto di Bioimmagini e Fisiopatologia del Sistema Nervoso Centrale, Italian National Research Council (CNR), Catania, Italy.
Brain Res Mol Brain Res. 1998 Feb;54(1):161-4. doi: 10.1016/s0169-328x(97)00335-5.
Receptor binding sites for pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP), positively coupled to adenylate cyclase, have been previously described in the retina of different mammalian species. In the present study, we determined the mRNA expression of PACAP/VIP receptor variants in the rat retina and investigated their coupling to phospholipase C in addition to adenylate cyclase. The two forms of PACAP, PACAP27 and PACAP38, induced a dose-dependent (1-100 nM) increase of cAMP and [3H]inositol monophosphate levels, whereas VIP stimulated, with lower potency and efficacy, cAMP formation only. Reverse transcription-PCR analysis in the rat retina detected both type-I (PACAP-R and PACAP-HOP splice variants) and type-II (VIP-I and -2) receptor-mRNAs. These data indicate that PACAP and VIP may interact with multiple receptor subtypes and activate one (VIP) or two (PACAP) signal transduction mechanisms in the rat retina.
垂体腺苷酸环化酶激活多肽(PACAP)和血管活性肠多肽(VIP)的受体结合位点与腺苷酸环化酶呈正偶联,此前已在不同哺乳动物物种的视网膜中有所描述。在本研究中,我们测定了大鼠视网膜中PACAP/VIP受体变体的mRNA表达,并除了研究它们与腺苷酸环化酶的偶联外,还研究了它们与磷脂酶C的偶联。两种形式的PACAP,即PACAP27和PACAP38,可诱导cAMP和[3H]肌醇单磷酸水平呈剂量依赖性(1-100 nM)增加,而VIP仅以较低的效力和效能刺激cAMP的形成。大鼠视网膜中的逆转录-聚合酶链反应分析检测到了I型(PACAP-R和PACAP-HOP剪接变体)和II型(VIP-I和-2)受体mRNA。这些数据表明,PACAP和VIP可能与多种受体亚型相互作用,并在大鼠视网膜中激活一种(VIP)或两种(PACAP)信号转导机制。